Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication

Molecular Cancer Therapeutics

Volumn 6, Issue 6, 2007, Pages 1755-1764

  Novak, Laura ^a   Igoucheva, Olga ^a   Cho, Stephanie ^a   Alexeev, Vitali ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ERADICATION THERAPY; HUMORAL IMMUNITY; IMMUNE RESPONSE; MELANOMA; MELANOMA CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLEEN CELL; WILD TYPE;

ANIMALS; ANTIBODY FORMATION; BASE SEQUENCE; CHEMOKINES, CC; DNA PRIMERS; IMMUNITY, CELLULAR; MELANOMA, EXPERIMENTAL; MICE;

EID: 34250771662     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0709     Document Type: Article

References (23)

1. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179-85.
2. Cyster JG. Leukocyte migration: scent of the T zone. Curr Biol 2000;10:R30-3.
3. Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, et al. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res 2001;61:2062-70.
4. Sharma S, Stolina M, Luo J, et al. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J Immunol 2000;164:4558-63.
5. Hisada M, Yoshimoto T, Kamiya S, et al. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT. Cancer Gene Ther 2004;11:280-8.
6. Yang S, Hillinger S, Ried K, et al. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin Cancer Res 2004;10:2891-901.
7. Yamano T, Kaneda Y, Huang S, Hiramatsu SH, Hoon DSB. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. Mol Ther 2006;13:194-202.
8. Elzaouk L, Pavlovic J, Moelling K. Analysis of antitumor activity elicited by vaccination with combinations of interleukin-12 DNAwith gp100 DNAor the chemokine CCL21 in vivo. Hum Gene Ther 2006;17:859-70.
9. Sodja C, Brown DL, Walker PR, Chaly N. Splenic T lymphocytes die preferentially during heat-induced apoptosis: NuMAreorg anization as a marker. J Cell Sci 1998;111:2305-13.
10. Fischer K, Andreesen R, Mackensen A. An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J Immunol Methods 2002;259:159-69.
11. Antibodies: a laboratory manual. In: Harlow E, editor. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1988. p. 119.
12. + NK helper cells. J Exp Med 2005;202:941-53.
13. + T cells. Cell Immunol 2004;231:75-84.
14. Rosenberg SA. Progress in human tumor immunology and immunotherapy. Nature 2001;411:380-4.
15. + T cells. J Clin Invest 2005;115:1616-26.
16. Harlin H, Kuna TV, Peterson AC, Meng Y, Gajewski TF. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites. Cancer Immunol Immunother 2006;55:1185-97.
17. + T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 2005;174:2591-601.
18. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003;300:337-9.
19. Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes. J Clin Invest 2000;105:R9-14.
20. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003;4:225-34.
21. Castiglioni P, Gerloni M, Zanetti M. Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells. Vaccine 2004;23:699-708.
22. + central memory T cells in protection from simian AIDS. J Immunol 2005;175:3502-7.
23. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A 2005;102:9571-6.